Author:
Berenguer-Ruiz Leticia,Gimenez-Martinez Juana,Palazón-Bru Antonio,Sempere Angel Perez
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference24 articles.
1. Butler M, Forte ML, Schwehr N, Carpenter A, Kane RL (2015) Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis. Rockville (MD): Agency for Healthcare Research and Quality (US). Report No.: 15-EHC012-EF
2. Hutchinson M (2011) Safety first, efficacy second in disease modifying therapies. Mult Scler 17:380–381.
https://doi.org/10.1177/1352458511402114
3. Novi G, Ghezzi A, Pizzorno M et al (2017) Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. Neurol Neuroimmunol Neuroinflamm 4(5):e377.
https://doi.org/10.1212/NXI.0000000000000377
(eCollection 2017 Sep)
4. Sempere AP, Berenguer-Ruiz L, Feliu-Rey E (2013) Rebound of disease activity during pregnancy after withdrawal of fingolimod. Eur J Neurol 20:e109–e110.
https://doi.org/10.1111/ene.12195
5. Kleerekooper I, van Kempen ZLE, Leurs CE et al (2018) Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurol Neuroimmunol Neuroinflamm 5:e424.
https://doi.org/10.1212/NXI.0000000000000424
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献